New cholesterol treatment guidelines 2013

1,995 views

Published on

This update represents the first major guideline revision since the National Cholesterol Education Program released
its Adult Treatment Panel III report in 2002

Published in: Health & Medicine
0 Comments
4 Likes
Statistics
Notes
  • Be the first to comment

No Downloads
Views
Total views
1,995
On SlideShare
0
From Embeds
0
Number of Embeds
7
Actions
Shares
0
Downloads
51
Comments
0
Likes
4
Embeds 0
No embeds

No notes for slide

New cholesterol treatment guidelines 2013

  1. 1. New Cholesterol Treatment Guideline2013 ACC-AHA Task Force Practice Guidelines November 12, 2013,
  2. 2. Algorithm Patients >21 yr. of age without heart failure (NYHA class II, III, or IV) or end-stage renal disease (undergoing haemodialysis) Screen for cardiovascular risk factors, measure LDL cholesterol Clinical Clinical atherosclerotic atherosclerotic CVD CVD High-intensity statin therapy DM I or II & age of 40–75 yr and LDL 70–189 mg/dl Calculate 10-yr risk of atherosclerotic CVD If risk <7.5%, moderateintensity statin therapy If risk .7.5%, highintensity statin therapy No DM & age of 40– 75 yr & LDL 70–189 mg/dl Calculate 10-yr risk of atherosclerotic CVD LDL ≥ 190 mg/dl High-intensity statin therapy If risk .7.5%, moderate-tohighintensity statin therapy
  3. 3. Intensity of statin therapy High-intensity statin therapy Moderate-intensity statin therapy Daily dose lowers LDL cholesterol level by approximately ≥50% on average Recommended: atorvastatin, 40 to 80 mg rosuvastatin, 20 to 40 mg  Daily dose lowers LDL cholesterol level by approximately 30 to <50% on average  Recommended: atorvastatin, 10 to 20 mg; rosuvastatin, 5 to 10 mg; simvastatin,20 to 40 mg; pravastatin, 40 to 80 mg; lovastatin, 40 mg; extended-release fluvastatin,80 mg; fluvastatin, 40 mg twice a day; pitavastatin, 2 to 4 mg
  4. 4. 10 Year risk score calculator • http://my.americanheart.org/cvriskcalculator or at http://www.cardiosource.org/
  5. 5. Advantage Only Statins Only LDL-Cholesterol
  6. 6. Limitation: No Rx for Below 21 Years Above 75 yrs. without atheromatous disease Other risk factor like family Hx of Premature atheromatous disease have not been taken into consideration

×